최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기The journal of immunology : official journal of the American Association of Immunologists, v.166 no.4, 2001년, pp.2658 - 2664
Doughty, Lesley A. (*Pediatrics and) , Nguyen, Khuong B. (†Molecular Microbiology and Immunology, Division of Biology and Medicine, Brown University, Providence, RI 02912) , Durbin, Joan E. (and) , Biron, Christine A. (‡Division of Pediatric Pathology, Department of Pediatrics, College of Medicine and Public Health, Ohio State University, Columbus, OH 43210)
AbstractUnderlying viral infections can heighten sensitivity and worsen cytokine-mediated disease following secondary inflammatory challenges. Mechanisms for this are poorly understood. The impact of the innate response to lymphocytic choriomeningitis virus (LCMV) infection on sensitivity to endotox...
10.7326/0003-4819-119-8-199310150-00001 Casey, L. C., R. A. Balk, R. C. Bone. 1993. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann. Intern. Med. 119: 771
10.4049/jimmunol.157.11.5049 Zhang, W. J., S. Sarawar, P. Nguyen, K. Daly, J. E. Rehg, P. C. Doherty, D. L. Woodland, M. A. Blackman. 1996. Lethal synergism between influenza infection and staphylococcal enterotoxin B in mice. J. Immunol. 157: 5049
10.1084/jem.181.3.901 Orange, J. O., T. P. Salazar-Mather, S. M. Opal, R. L. Spencer, A. H. Miller, B. S. McEwen, C. A. Biron. 1995. Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids. J. Exp. Med. 181: 901
10.4049/jimmunol.162.9.5238 Nguyen, K. B., C. A. Biron. 1999. Synergism for cytokine-mediated disease during concurrent endotoxin and viral challenges: roles for NK and T cell IFN-γ production. J. Immunol. 162: 5238
Ray, G. C.. 1994. Influenza, respiratory syncytial, adenovirus, and other respiratory viruses. K. J. Ryan, ed. Sherris Medical Microbiology: An Introduction to Infectious Diseases 3rd Ed.456 Appleton and Lange Paramount Publishing Business and Professional Group, East Norwalk, CT.
10.1001/jama.1987.03390080043027 MacDonald, K. L., M. T. Osterholm, C. W. Hedberg, C. G. Schrock, J.M. Peterson Jentzen, S. A. Leonard, P. M. Schlievert. 1987. Toxic shock syndrome: a newly recognized complication of influenza and influenza-like illness. J. Am. Med. Assoc. 257: 1053
10.1093/infdis/118.5.449 Degre, M., L. A. Glasgow. 1968. Synergistic effect in viral-bacterial infection. I. Combined infection of the respiratory tract in mice with parainfluenza virus and Haemophilus influenzae. J. Infect. Dis. 118: 449
10.1136/bmj.313.7065.1145a Barnes, A. J., A. S. Johnson, M. P. Shelly, C. I. Orton. 1996. Bacterial superinfection in chickenpox but it can occur at any age. Br. Med. J. 313: 1145
10.1542/peds.103.4.783 Zerr, D. M., E. R. Alexander, J. S. Duchin, L. A. Koutsky, C. E. Rubens. 1999. A case-control study of necrotizing fasciitis during primary varicella. Pediatrics 103: 783
10.1128/iai.41.2.618-623.1983 Jones, W. T., J. H. Menna, D. E. Wennerstrom. 1983. Lethal synergism induced in mice by influenza type A and type Ia group B streptococci. Infect. Immun. 41: 618
10.1093/infdis/170.5.1189 Sarawar, S. R., M. A. Blackman, P. C. Doherty. 1994. Superantigen shock in mice with inapparent viral infection. J. Infect. Dis. 170: 1189
10.1086/514017 Nansen, A., J. P. Christensen, O. Marker, A. R. Thomsen. 1997. Sensitization to lipopolysaccharide in mice with asymptomatic viral infection: the role of T cell dependent production of interferon γ. J. Infect. Dis. 176: 151
10.4049/jimmunol.155.9.4497 Pullen, L. C., S. H. Park, S. D. Miller, M. C. Dal Canto, B. S. Kim. 1995. Treatment with bacterial LPS renders genetically resistant C57BL/6 mice susceptible to Theiler’s virus-induced demyelinating disease. J. Immunol. 155: 4497
10.1111/j.1348-0421.1986.tb03003.x Leung, W. C., K. Hashimoto. 1986. Modification of susceptibility to K. pneumoniae during murine cytomegalovirus infection. Microbiol. Immunol. 30: 761
Murray, P. R., K. S. Rosenthal, G. S. Kobayashi, M. A. Pfaller. 1998. Orthomyxoviruses. M. Brown, ed. Medical Microbiology 3rd Ed.477 Mosby-Year Book, St. Louis, MO.
10.1084/jem.180.3.907 Ozmen, L., M. Pericin, J. Hakimi, R. A. Chizzonite, M. Wysocka, G. Trinchieri, M. Gately, G. Garotta. 1994. Interleukin 12, interferon-γ, and tumor necrosis factor-α are the key cytokines of the generalized Schwartzman reaction. J. Exp. Med. 180: 907
10.1128/iai.62.10.4244-4249.1994 Heinzel, F. P., R. M. Rerko, P. Ling, J. Hakimia, D. S. Schoenhaut. 1994. Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of γ interferon. Infect. Immun. 62: 4244
10.1002/eji.1830250307 Wysocka, M., M. Kubin, L. Q. Vieira, L. Ozmen, G. Garotta, P. Scott, G. Trinchieri. 1995. Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol. 25: 672
10.1084/jem.171.6.1853 Heremans, H., J. Van Damme, C. Dillen, R. Dijkmans, A. Billiau. 1990. Interferon-γ, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice. J. Exp. Med. 171: 1853
10.4049/jimmunol.145.9.2920 Heinzel, F. P.. 1990. The role of IFN-γ in the pathology of experimental endotoxemia. J. Immunol. 145: 2920
10.4049/jimmunol.135.6.3972 Beutler, B. A., I. W. Milsark, A. Cerami. 1985. Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. J. Immunol. 135: 3972
10.1126/science.3895437 Beutler, B., I. W. Milsark, A. C. Cerami. 1985. Passive immunization against cachectin-tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229: 869
10.1016/0092-8674(93)90134-C Pfeffer, K., T. Matsuyama, T. M. Kundig, A. Wakeham, K. Kishihara, A. Shchinian, K. Wiegmann, P. S. Ohashi, M. Kronke, T. W. Mak. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73: 457
10.1084/jem.165.3.657 Lehmann, V., M. A. Freudenberg, C. Galanos. 1987. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J. Exp. Med. 165: 657
10.1073/pnas.84.12.4273 Kettelhut, I. C., W. Fiers, A. L. Goldberg. 1987. The toxic effects of tumor necrosis factor in vivo and their prevention by cyclo-oxygenase inhibitors. Proc. Natl. Acad. Sci. USA 84: 4273
10.1172/JCI113733 Starnes, H. F., Jr, R. S. Warren, M. Jeevanandam, J. L. Gabrilove, W. Larchian, H. F. Oettgen, M. F. Brennan. 1988. Tumor necrosis factor and the acute metabolic response to tissue injury in man. J. Clin. Invest. 82: 1321
10.1038/318665a0 Aggarwal, B. B., T. E. Eessalu, P. E. Hass. 1985. Characterization of receptors for human tumor necrosis factor and their regulation by γ-interferon. Nature 318: 665
10.4049/jimmunol.136.7.2441 Tsujimoto, M., Y. K. Yip, J. Vilcek. 1986. Interferon-γ enhances expression of cellular receptors for tumor necrosis factor. J. Immunol. 136: 2441
10.4049/jimmunol.149.5.1666 Doherty, G. M., J. R. Lange, H. N. Langstein, R. Alexander, C. M. Buresh, J. A. Norton. 1992. Evidence for IFN-γ as a mediator of the lethality of endotoxin and tumor necrosis factor-α. J. Immunol. 149: 1666
10.4049/jimmunol.142.7.2325 Hamilton, T. A., N. Bredon, Y. Ohmori, C. S. Tannenbaum. 1989. IFN-γ and IFN-β independently stimulate the expression of lipopolysaccharide-inducible genes in murine peritoneal macrophages. J. Immunol. 142: 2325
10.4049/jimmunol.141.5.1536 Moon, D. K., C. L. Geczy. 1988. Recombinant IFN-γ synergizes with lipopolysaccharide induce macrophage membrane procoagulants. J. Immunol. 141: 1536
Biron, C. A., and G. C. Sen. 2001. Interferons and other cytokines. In Fields Virology, 4th Ed. D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus, eds. Lippincott, Williams, & Wilkins, In press.
10.1006/smim.1998.0138 Biron, C. A.. 1998. Role of early cytokines, including alpha and beta interferons (IFN-α/β), in innate and adaptive immune responses to viral infections. Semin. Immunol. 10: 383
10.1073/pnas.94.2.634 Cousens, L. P., J. S. Orange, H. C. Su, C. A. Biron. 1997. Interferon-α/β inhibition of interleukin 12 and interferon-γ production in vitro and endogenously during viral infection. Proc. Natl. Acad. Sci. USA 94: 634
10.1038/76940 Nguyen, K. B., L. C. Cousens, L. A. Doughty, G. C. Pien, J. E. Durbin, C. A. Biron. 2000. Interferon-α/β-mediated inhibition and promotion of interferon-γ: STAT1 resolves a paradox. Nat. Immunol. 1: 70
Pfeffer, L. M., C. A. Dinarello, R. B. Herberman, B. R. G. Williams, E. C. Borden, R. Bordens, M. R. Walter, T. L. Nagabhushan, P. P. Trotta, S. Pestka. 1998. Biological properties of recombinant α-interferons: 40th anniversary of the discovery of interferons. Cancer Res. 58: 2489
10.1200/JCO.2000.18.12.2444 Kirkwood, J. M., J. G. Ibrahim, V. K. Sondak, J. Richards, L. E. Flaherty, M. S. Ernstrobb, T. J. Smith, U. Rao, M. Steele, R. H. Blum. 2000. High- and low-dose interferon α-2b in high-risk melanoma: analysis of intergroup trial E1690/S9111/C9190. J Clin. Oncol. 18: 2444
Giosue, S., M. Casarini, F. Ameglio, P. Zangrilli, M. Palla, A. M. Altieri. 2000. Aerosolized interferon-α treatment in patients with multi-resistant pulmonary tuberculosis. Eur. Cytokine Network 11: 99
Ganapati, R., V. V. Pai, U. Banerji, J. Thomas, B. Saha. 1997. A multicenter study of recombinant interferon-α 2b in the treatment of multibacillary leprosy. Int. J. Lepr. Other Mycobact. Dis. 65: 495
10.1073/pnas.91.20.9402 Wang, B., C. A. Biron, J. She, K. Higgins, M. J. Sunshine, E. Lacy, N. Lonberg, C. Terhorst. 1994. A block in both early T lymphocyte and natural killer cell development in transgenic mice with high copy numbers of the human CD3ε gene. Proc. Natl. Acad. Sci. USA 9: 9402
10.1016/0092-8674(92)90030-G Mombaerts, P., J. Iacomini, R. S. Johnson, K. Herrup, S. Tonegawa, V. E. Papaioannou. 1992. RAG-1 deficient mice have no mature B and T lymphocytes. Cell 68: 869
10.4049/jimmunol.160.10.5007 Su, H. C., L. P. Cousens, L. D. Fast, M. K. Slifka, R. D. Bungiro, R. Ahmed, C. A. Biron. 1998. CD4+ and CD8+ T cell interactions in IFN-γ and IL-4 responses to viral infections: requirements for IL-2. J. Immunol. 160: 5007
10.1084/jem.182.4.1045 Orange, J. S., B. Wang, C. Terhorst, C. A. Biron. 1995. Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182: 1045
10.1038/382171a0 Thierfelder, W. E., J. M. van Deursen, K. Yamamoto, R. A. Tripp, T. Sarawar, R. T. Carson, M. Y. Sangster, D. A. Vignali, P. C. Doherty, G. C. Grosveld, J. N. Ihle. 1996. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382: 171
10.4049/jimmunol.162.12.7417 Kantakamalakul, W., A. D. Politis, S. Marecki, T. Sullivan, K. Ozato, M. J. Fenton, S. N. Vogel. 1999. Regulation of IFN consensus sequence binding protein expression in murine macrophages. J. Immunol. 162: 7417
10.1128/IAI.67.1.206-212.1999 Held, T. K., X. Weihua, L. Yuan, D. V. Kalvakolanu, A. S. Cross. 1999. γ interferon augments macrophage activation by lipopolysaccharide by two distinct mechanisms, at the signal transduction level via an autocrine mechanism involving tumor necrosis factor α and interleukin 1. Infect. Immun. 67: 206
10.1002/eji.1830221211 Tzung, S. P., T. C. Mahl, P. Lance, V. Andersen, S. A. Cohen. 1993. Interferon-α prevents endotoxin-induced mortality in mice. Eur. J. Immunol. 22: 3097
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.